Localization of the low-density lipoprotein receptor-related protein regions involved in binding to the A2 domain of coagulation factor VIII

Thrombosis and Haemostasis

Volumn 98, Issue 6, 2007, Pages 1170-1181

  Sarafanov, Andrey G ^a,d   Makogonenko, Evgeny M ^a   Andersen, Olav M ^b   Mikhailenko, Irina A ^a   Ananyeva, Natalya M ^a   Khrenov, Alexey V ^a   Shima, Midori ^c   Strickland, Dudley K ^a   Saenko, Evgueni L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Coagulation factorVIII; Low density lipoprotein receptor related protein

Indexed keywords

BLOOD CLOTTING FACTOR 8; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BINDING AFFINITY; BINDING SITE; CATABOLISM; CELL CULTURE; CONTROLLED STUDY; INTERNALIZATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ANIMALS; BACULOVIRIDAE; BINDING, COMPETITIVE; CELL LINE; ENDOCYTOSIS; FACTOR VIII; FIBROBLASTS; HUMANS; IODINE RADIOISOTOPES; LDL-RECEPTOR RELATED PROTEINS; LIGANDS; MICE; MICE, INBRED BALB C; MOLECULAR CHAPERONES; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; POINT MUTATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; SURFACE PLASMON RESONANCE; TIME FACTORS;

EID: 36949032960     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-05-0353     Document Type: Article

References (50)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-10370.
2. Fay PJ. Factor VIII structure and function. Int J Hematol 2006; 83: 103-108.
3. Saenko EL, Yakhyaev AV, Mikhailenko I, et al. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem 1999; 274: 37685-37692.
4. Lenting PJ, Neels JG, van Den Berg BM, et al. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem 1999; 274: 23734-23739.
5. Schwarz HP, Lenting PJ, Binder B, et al. Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Wille-brand factor-deficient mice. Blood 2000; 95: 1703-1708.
6. Bovenschen N, Herz J, Grimbergen JM, et al. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood 2003; 101: 3933-3939.
7. Strickland DK, Ranganathan S. Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J Thromb Haemost 2003; 1: 1663-1670.
8. Bu G, Remike S, Receptor-associated protein is a folding chaperone for low density lipoprotein receptor-related protein. J Biol Chem 1996; 271: 22218-2224.
9. Obermoeller LM, Warshawsky I, Wardell MR, et al. Differential functions of triplicated repeats suggest two independent roles for the receptor-associated protein as a molecular chaperone. J Biol Chem 1997; 272: 10761-10768.
10. Turecek PL, Schwarz HP, Binder BR. In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factor. Blood 2000; 95: 3637-3638.
11. Bovenschen N, Mertens K, Hu L, et al. LDL receptor cooperates with LDL receptor-related protein in regulating plasma levels of coagulation factor VIII in vivo. Blood 2005; 106: 906-912.
12. Marchetti G, Lunghi B, Legnani C, et al. Contribution of low density lipoprotein receptor-related protein genotypes to coagulation factor VIII levels in thrombotic women. Haematologica 2006; 91: 1261-1263.
13. Russell DW, Brown MS, Goldstein JL. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J Biol Chem 1989; 264: 21682-21688.
14. Fass D, Blacklow S, Kim PS, et al. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 1997; 388: 691-693.
15. Dolmer K, Huang W, Gettins PG. Characterization of the calcium site in two complement-like domains from the low-density lipoprotein receptor-related protein (LRP) and comparison with a repeat from the low-density lipoprotein receptor. Biochemistry 1998; 37: 17016-17023.
16. Neels JG, van Den Berg BM, Lookene A, et al. The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties. J Biol Chem 1999; 274: 31305-31311.
17. Andersen OM, Christensen LL, Christensen PA, et al. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor- associated protein (RAP). A conserved acidic residue in the complement- type repeats is important for recognition of RAP. J Biol Chem 2000; 275: 21017-21024.
18. Huang W, Dolmer K, Gettins PG. NMR solution structure of complement-like repeat CR8 from the low density lipoprotein receptor-related protein. J Biol Chem 1999; 274: 14130-14136.
19. Andersen OM, Petersen HH, Jacobsen C, et al. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-ipoprotein-receptor-related protein. Biochem J 2001; 357: 289-296.
20. Lazic A, Dolmer K, Strickland DK, et al. Dissection of RAP-LRP interactions: binding of RAP and RAP fragments to complement-like repeats 7 and 8 from ligand binding cluster II of LRP. Arch Biochem Biophys 2006; 450: 167-175.
21. Sarafanov AG, Makogonenko EM, Pechik IV, et al. Identification of coagulation factor VIII A2 domain residues forming the binding epitope for low-density lipoprotein receptor-related protein. Biochemistry 2006; 45: 1829-1840.
22. Bovenschen N, Boertjes RC, van Stempvoort G, et al. Low density lipoprotein receptor-related protein and factor IXa share structural requirements for binding to the A3 domain of coagulation factor VIII. J Biol Chem 2003; 278: 9370-9377.
23. Saenko EL, Scandella D. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von Willebrand factor. J Biol Chem 1997; 272: 18007-18014.
24. Lethagen S, Berntorp E, Nilsson IM. Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III. Ann Hematol 1992; 65: 253-259.
25. Bovenschen N, van SG, Voorberg J, et al. Proteolytic cleavage of factor VIII heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain. J Thromb Haemost 2006; 4: 1487-1493.
26. Murphy JE, Mei B, Pan C, et al. Towards a new therapy for hemophilia A: Evaluation of multiple approaches to prolong the in vivo efficacy of recombinant factor VIII. Blood 2006; 108: Abstract 1606.
27. Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa. J Biol Chem 1992; 267: 13246-13250.
28. Fay PJ, Beattie TL, Regan LM, et al. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis. J Biol Chem 1996; 271: 6027-6032.
29. Brinkman HJ, Koster P, Mertens K, et al. Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation. Biochem J 1997; 323: 735-740.
30. Saenko EL, Shima M, Gilbert GE, et al. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inbibition. J Biol Chem 1996; 271: 27424-27431.
31. Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962.
32. Lollar P, Fay PJ, Fass D. Factor VIII and factor VIIIa. Methods Enzymol 1999; 222: 128-143.
33. Ashcom JD, Tiller SE, Dickerson K, et al. The human alpha 2-macroglobulin receptor: identification of a 420-kD cell surface glycoprotein specific for the activated conformation of alpha 2-macroglobulin. J Cell Biol 1990; 110: 1041-1048.
34. Williams SE, Ashcom JD, Argraves WS, et al. A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Multiple regulatory sites for 39-kDa receptor-associated protein. J Biol Chem 1992; 267: 9035-9040.
35. Ulery PG, Beers J, Mikhailenko I, et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 2000; 275: 7410-7415.
36. Sarafanov A, Saenko E. High-throughput optimization of protein expression in the baculovirus system based on determination of relative expression efficiency of viral stocks. Anal Biochem 2004; 328: 98-100.
37. Sarafanov AG, Ananyeva NM, Shima M, et al. Cell surface heparan sulfate proteoglycans participate in factor viii catabolism mediated by low density lipoprotein receptor-related protein. J Biol Chem 2001; 276: 11970-11979.
38. Horn IR, van Den Berg BM, van der Meijden PZ, et al. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding. J Biol Chem 1997; 272: 13608-13613.
39. Leyte A, Van Schijndel HB, Niehrs C, et al. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1991; 266: 740-746.
40. Chappell DA, Fry GL, Waknitz MA, et al. The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J Biol Chem 1992; 267: 25764-25767.
41. Kounnas MZ, Chappell DA, Wong H, et al. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J Biol Chem 1995; 270: 9307-9312.
42. Orlando RA, Exner M, Czekay RP, et al. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Proc Natl Acad Sci USA 1997; 94: 2368-2373.
43. Quinn KA, Grimsley PG, Dai YP, et al. Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J Biol Chem 1997; 272: 23946-23951.
44. Fisher C, Beglova N, Blacklow SC. Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol Cell 2006; 22: 277-283.
45. Jensen GA, Andersen OM, Bonvin AM, et al. Binding site structure of one LRP/RAP complex - implications for a common ligand/receptor binding motif. J Mol Biol 2006; 362: 700-716.
46. Sarafanov A, Makogonenko E, Andersen O, et al. Identification of regions in low-density lipoprotein receptor-related protein responsible for interaction with A2 and A1/A3-C1-C2 portions of coagulation factor VIII. J Thromb Haemost 2005; 3: Abstract OR248.
47. Sarafanov A, Makogonenko E, Andersen O, et al. Fragments of activated coagulation factor VIII bind to multiple sites within low-density lipoprotein receptor-related protein. Blood 2005; 106: 298a (Abstract 1019).
48. Meijer AB, Rohlena J, van der Zwaan C, et al. Functional duplication of ligand-binding domains within low-density lipoprotein receptor-related protein for interaction with receptor associated protein, alpha(2)-macroglobulin, factor IXa and factor VIII. Biochim Biophys Acta 2007; 1774: 714-722.
49. Fay PJ, Koshibu K. The A2 subunit of factor VIIIa modulates the active site of factor IXa. J Biol Chem 1998; 273: 19049-19054.
50. Harpel PC. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. J Clin Invest 1981; 68: 46-55.